Artificial Intelligence In Life Sciences Market Report 2026

Artificial Intelligence In Life Sciences Market Overview

• Artificial Intelligence In Life Sciences market size has reached to $3.59 billion in 2025 • Expected to grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 23.8% • Growth Driver: Surge In Remote Patient Monitoring Boosts AI Adoption In Lifesciences • Market Trend: Technological Advancements In The Artificial Intelligence In Life Sciences Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Life Sciences Market?

Artificial intelligence (AI) in life sciences refers to the application of AI technologies and techniques in various domains within the life sciences industry. The integration of AI in life sciences aims to enhance and expedite processes, improve decision-making, and generate valuable insights from complex data sets. The main offerings of artificial intelligence in life sciences are software, hardware, and services. The software uses AI algorithms to analyze vast chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These are deployed through on-premises, and cloud-based and are used in various applications such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.

What Is The Artificial Intelligence In Life Sciences Market Growth Forecast?

The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 23.8%. The growth in the forecast period can be attributed to increasing investments in personalized medicine, rising deployment of ai-enabled laboratory automation, expansion of cloud-based life science platforms, growing collaboration between tech and life science firms, increasing regulatory acceptance of ai-driven insights. Major trends in the forecast period include increasing integration of ai across life science workflows, rising adoption of AI-driven data analytics platforms, growing use of automation in laboratory operations, expansion of AI-based precision medicine applications, enhanced focus on accelerating research outcomes.

Global Artificial Intelligence In Life Sciences Market Segmentation

1) By Offering: Software, Hardware, Services 2) By Deployment: On-Premises, Cloud-Based 3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring Subsegments: 1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS) 2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies 3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

What Is The Driver Of The Artificial Intelligence In Life Sciences Market?

The increasing interest in real-time remote patient monitoring (RPM) systems is expected to propel the growth of artificial intelligence in the life sciences market going forward. A remote patient monitoring system is a technology-driven healthcare solution designed to monitor patients' health outside of traditional healthcare settings. AI in life sciences contributes significantly to remote patient monitoring by providing continuous, personalized, and data-driven insights that enable proactive healthcare management. For instance, in April 2025, according to the Peterson Center on Healthcare, a US-based non-profit organization reported that spending for remote therapeutic monitoring (RTM) in Traditional Medicare rose from $2.2 million in 2022 to $10.4 million in 2023. Further, in 2023, 451,000 patients in Traditional Medicare used RPM services. Therefore, the increasing interest in real-time remote patient monitoring (RPM) systems is driving the growth of artificial intelligence in the life sciences market.

Key Players In The Global Artificial Intelligence In Life Sciences Market

Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Global Artificial Intelligence In Life Sciences Market Trends and Insights

Major companies operating in the artificial intelligence in the life sciences market are focusing on innovative products with technological advancements, such as drug discovery software, to sustain their position in the market. Drug discovery software refers to a category of computer programs and applications designed to assist pharmaceutical and biotechnology researchers in the process of discovering new drugs. For instance, in December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a groundbreaking drug discovery software. As the first-ever of its kind, it connects virtual molecule design with real-world manufacturability, using generative AI, machine learning, and computer-aided drug design. AIDDISON efficiently identifies drug candidates from vast possibilities, considering crucial properties like non-toxicity and solubility. Its ability to bridge the gap between virtual molecule design and real-world manufacturability is a notable application of artificial intelligence in the life sciences sector.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market?

In June 2023, Varix, a US-based pharma commercial operations company, acquired Start-up.ai for an undisclosed amount. Varix's acquisition of Start-up.ai is to strengthen its capabilities in artificial intelligence (AI) and machine learning (ML) for the pharmaceutical commercial operations sector. Start-up. AI is an Israel-based AI-driven commercial optimization platform provider to enhance its life science AI capabilities.

Regional Outlook

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Life Sciences Market?

The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Life Sciences Market Report 2026?

The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.